Request
More Information
via our confidential request form

da Vinci ® Robotic Radical Prostatectomy at Our Los Angeles Center

More U.S. men choose da Vinci Surgery than any other treatment for prostate cancer. Thanks to breakthrough surgical technology, the USC Institute of Urology and other leading urologists have partnered with miVIP Surgery Centers to offer a minimally invasive treatment for prostate cancer – the da Vinci Prostatectomy – at two centers located in Beverly Hills and Orange County, California. USC Urology is the first and only team in the country performing outpatient, urethral catheter-free robotic prostatectomy, so that patients can return home the same day and start getting back to normal activities. miVIP is the first and only freestanding outpatient multispecialty surgery center in the world offering outpatient, urethral-catheter-free robotic prostatectomy.

The da Vinci Surgical System is a state-of-the-art surgical platform with 3D, high-definition vision and miniaturized, wristed surgical instruments designed to help doctors take surgery beyond the limits of the human hand. Though it is often called a “robot,” da Vinci cannot act on its own – surgery is performed entirely by your doctor from start to finish. By overcoming the limitations of traditional open and laparoscopic surgery, da Vinci is changing the experience of surgery for people around the world.

Why da Vinci? It’s a major surgery performed through the smallest of incisions. Imagine having the benefits of a definitive treatment performed by world-leading robotic surgeons with the following benefits:

Better Cancer Control

Studies show that experienced da Vinci surgeons achieve better cancer control compared to open surgeons. Positive margin rates are a measure of cancer cells left behind, and da Vinci gives consistently lower numbers.

Faster Return of Erectile Function

Studies show patients who are potent prior to surgery experience a faster return of erectile function than patients who have open surgery. The rate of impotence among patients is reduced to 2 percent from 30 percent when surgery is performed using the da Vinci System.

Better Chance for Return of Urinary Continence

Recent studies show more patients have full return of urinary continence within six months as compared to patients having open surgery.

There are many more benefits of miVIP Surgery Centers' da Vinci Surgery:

  • No hospital stay required
  • Less blood loss
  • Lower risk of complications
  • Lower risk of wound infection
  • Fewer or no days with catheter
  • Less pain
  • Faster recovery and return to normal activities

 

Open Surgery vs. Radiation Therapy

While long-term data is not yet available comparing da Vinci Surgery to radiation, there are large studies comparing open surgery with radiation. This evidence suggests that removing the prostate (radical prostatectomy) offers patients a better chance of survival compared to radiation.

The following table compares patient outcomes following open surgery for prostate cancer – considered the gold standard treatment for localized cancer – and radiation or radiotherapy (brachytherapy and external beam radiation). Data are provided on survival, cancer recurrence, incidence of rectal and bladder cancer, bowel function, urinary issues and long-term erectile function.

In the table below, radical prostatectomy includes all approaches to prostate surgery: open surgery through large incisions, manual laparoscopic prostatectomy, as well as da Vinci robotic-assisted prostatectomy. As shown in the table, all types of surgery offer measurable advantages over radiation in terms of outcomes and survival rates.

Outcome Comparison: Surgery vs. Radiation

da Vinci vs. Open vs. Conventional Laparoscopy

Outcome Radical Prostatectomy Radiation*

Survival duration compared to conservative disease management

8.6 years

4.6 years

15-year prostate cancer survival rate

92%

87%

Survival rate for high-grade cancer patients

44% increase in overall survival rate vs. radiotherapy

 

-

Risk of cancer-specific death for high-grade cancer patients

49% less risk vs. radiotherapy

 

-

Bowel function impairment

-

Significantly greater vs. surgery

Disease-specific long-term quality of life

Stable

Unstable

Painful urination (at 24 month followup)

2.1% of patients

19% of patients

*External Beam Radiation Therapy (EBRT) unless otherwise noted in the citation.

Long-Term Survival for Localized Prostate Cancer

Like with any cancer treatment, the first priority is survival. A recent study suggests there is a greater chance of long-term survival for patients undergoing surgery when compared to other treatments.

In this large study of patients receiving treatment for prostate cancer, those receiving radiation (including IMRT) and hormone therapy were two and three times more likely to die, respectively, than radical prostatectomy (surgery) patients. In fact, surgery patients who had their cancerous prostate removed had the lowest cancer death rate.

In a previous study that included watchful waiting, the patients who had a radical prostatectomy had a higher prostate cancer survival rate than men choosing other treatments.

Web Analytics